HOME >> BIOLOGY >> NEWS
Mouse, stripped of a key gene, resists diabetes

MADISON - An engineered mouse, already known to be immune to the weight gain ramifications of a high-calorie, high-fat diet, now seems able to resist the onset of diabetes.

The mouse, stripped of a gene known as SCD-1, is apparently impervious to the negative effects of the type of diet that, for many people, has significant health and social consequences.

"We think this animal model may be protected against diabetes," says James Ntambi, a University of Wisconsin-Madison professor of biochemistry and Steenbock professor of nutrition, and the senior author of a report describing the remarkable mouse in this week's (Sept. 1) online editions of the Proceedings of the National Academy of Sciences (PNAS).

The new finding is important because it provides critical genetic and biochemical clues to diet, obesity and the onset of a disease that affects as much as 6 percent of the U.S. population.

Type II diabetes, which accounts for about 90 percent of the incidence of diabetes in the United States, is a chronic disease caused by a problem in the way the body makes or uses insulin. Insulin is a hormone secreted by the pancreas that, under healthy circumstances, plays an essential role in moving glucose from blood to cells where the sugar's energy is expended.

In many instances, obesity and diabetes go hand in hand. Between 75 and 80 percent of people with type II diabetes are obese, although the disease can also develop in lean people, especially the elderly.

The discovery of a gene that seems to exercise significant influence over both weight gain and glucose regulation promises a potentially significant window into both conditions and their relationship. The gene makes an enzyme called SCD. It affects the production of fatty acids, and because humans have SCD-1 equivalents, the new finding helps explain why some people, who may lack the gene, remain lean and diabetes free, despite a rich, fatty diet.

"We are beginnin
'"/>

Contact: James Ntambi
ntambi@biochem.wisc.edu
608-265-3700
University of Wisconsin-Madison
2-Sep-2003


Page: 1 2

Related biology news :

1. Plant immune systems take two aspirin gene, offers hope for disease control
2. Study suggests interplay of gene, stress can predict depression
3. One gene, two important proteins
4. One gene, two eye diseases?
5. Study to help solve health problems by understanding gene, protein behavior in cells
6. Researchers characterize mollusk insulin gene, find unique peptide
7. Breast cancer relapse rates appear higher in women who have cancer-causing gene, Yale study finds
8. Researchers determine how hospital staph resists antibiotics
9. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
10. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
11. A probable cause for high blood pressure identified - shows links with diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2020)... ... March 03, 2020 , ... Amplify Surgical, Inc., today announces that the company ... System. , The landmark case was performed by Dr. Ali Najafi at ... noted, “dualX has completely changed the game for expandable interbodies. The ability to ...
(Date:3/2/2020)... , ... March 02, 2020 , ... Nominations are now ... co-founded by the Security Industry Association (SIA) and SecureIDNews and ... Women in Security Forum . The recipients of this year’s Women in Biometrics Awards ...
(Date:2/28/2020)... ... February 27, 2020 , ... ... explore innovative treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically ... This segment will focus on a novel platform developed by Deka Biosciences, Inc. ...
Breaking Biology News(10 mins):
(Date:3/27/2020)... ... March 25, 2020 , ... Enso ... centrally in the midwest for high-quality, quick-turn, board-certified reporting. In an effort ... independent, professional team that is focused on incredible quality, turnaround time and ...
(Date:3/19/2020)... FREDERICK, Md. (PRWEB) , ... ... ... announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit ... gene-modified cell therapies for ovarian cancer and other solid tumor indications. The ...
(Date:3/13/2020)... ... March 12, 2020 , ... ... APC Microbiome Ireland SFI Research Center (APC), a pioneer in the field of ... and play a significant role in human health, based at University College Cork ...
(Date:3/10/2020)... ... 10, 2020 , ... Ortho Clinical Diagnostics, a global leader of in vitro ... Sera, ID-MTS, a suite of extended antigen in a gel testing format used for ... VISION® and ORTHO VISION® Max in the United States and Canada. The clearances allow ...
Breaking Biology Technology:
Cached News: